Aviva’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,045
Closed -$210K 864
2025
Q4
$210K Sell
6,045
-381
-6% -$29.9K ﹤0.01% 864
2025
Q3
$534K Sell
6,426
-137
-2% -$9.91K ﹤0.01% 709
2025
Q2
$482K Sell
6,563
-3,805
-37% -$276K ﹤0.01% 764
2025
Q1
$1.18M Sell
10,368
-588
-5% -$35.8K ﹤0.01% 613
2024
Q4
$552K Sell
10,956
-6,371
-37% -$334K ﹤0.01% 785
2024
Q3
$802K Sell
17,327
-3,893
-18% -$138K ﹤0.01% 626
2024
Q2
$689K Sell
21,220
-5,265
-20% -$144K ﹤0.01% 680
2024
Q1
$667K Buy
26,485
+4,072
+18% +$96.2K ﹤0.01% 749
2023
Q4
$728K Buy
+22,413
New +$615K ﹤0.01% 724
2022
Q1
Sell
-127,855
Closed -$2.53M 1069
2021
Q4
$2.53M Buy
127,855
+48,808
+62% +$990K 0.01% 791
2021
Q3
$1.56M Buy
+79,047
New +$1.65M 0.01% 876
2021
Q1
Sell
-70,676
Closed -$1.85M 950
2020
Q4
$1.85M Sell
70,676
-57,297
-45% -$1.21M 0.01% 691
2020
Q3
$2.23M Sell
127,973
-8,376
-6% -$133K 0.01% 737
2020
Q2
$2.29M Sell
136,349
-180,494
-57% -$2.54M 0.01% 699
2020
Q1
$3.77M Buy
+316,843
New +$3.92M 0.03% 506

Other funds holding CORT